263 related articles for article (PubMed ID: 11520785)
1. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax.
Somervaille TC; Linch DC; Khwaja A
Blood; 2001 Sep; 98(5):1374-81. PubMed ID: 11520785
[TBL] [Abstract][Full Text] [Related]
2. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
3. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
Myklebust JH; Blomhoff HK; Rusten LS; Stokke T; Smeland EB
Exp Hematol; 2002 Sep; 30(9):990-1000. PubMed ID: 12225790
[TBL] [Abstract][Full Text] [Related]
4. The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells.
Paiboonsukwong K; Choi I; Matsushima T; Abe Y; Nishimura J; Winichagoon P; Fucharoen S; Nawata H; Muta K
Int J Hematol; 2003 Dec; 78(5):421-8. PubMed ID: 14704034
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
Sui X; Krantz SB; Zhao ZJ
Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.
Panka DJ; Mano T; Suhara T; Walsh K; Mier JW
J Biol Chem; 2001 Mar; 276(10):6893-6. PubMed ID: 11145953
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease.
Shimoke K; Chiba H
J Neurosci Res; 2001 Mar; 63(5):402-9. PubMed ID: 11223915
[TBL] [Abstract][Full Text] [Related]
9. Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways.
Huang HM; Huang CJ; Yen JJ
Blood; 2000 Sep; 96(5):1764-71. PubMed ID: 10961875
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
Sui X; Krantz SB; You M; Zhao Z
Blood; 1998 Aug; 92(4):1142-9. PubMed ID: 9694701
[TBL] [Abstract][Full Text] [Related]
12. Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway.
Sulpice E; Bryckaert M; Lacour J; Contreres JO; Tobelem G
Blood; 2002 Nov; 100(9):3087-94. PubMed ID: 12384403
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S
J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphatidylinositol 3-kinase sensitizes vascular endothelial cells to cytokine-initiated cathepsin-dependent apoptosis.
Madge LA; Li JH; Choi J; Pober JS
J Biol Chem; 2003 Jun; 278(23):21295-306. PubMed ID: 12663669
[TBL] [Abstract][Full Text] [Related]
15. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent.
Esfandiarei M; Luo H; Yanagawa B; Suarez A; Dabiri D; Zhang J; McManus BM
J Virol; 2004 Apr; 78(8):4289-98. PubMed ID: 15047842
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
19. Activation of ERK1/2 by deltaRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways.
Weston CR; Balmanno K; Chalmers C; Hadfield K; Molton SA; Ley R; Wagner EF; Cook SJ
Oncogene; 2003 Mar; 22(9):1281-93. PubMed ID: 12618753
[TBL] [Abstract][Full Text] [Related]
20. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]